Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ Familycare rebate prohibitions.

This bill (S 1399, "Clinical Laboratory Services Reimbursement and Vulnerable Patient Discount Act") permits clinical laboratories to offer discounts to patients facing financial hardship without reducing NJ FamilyCare reimbursement rates or violating anti-rebate rules. It directly affects labs serving vulnerable populations - including uninsured, homeless, or low-income patients seeking services like drug testing for substance use disorder treatment - by allowing them to discount charges based on documented financial hardship (e.g., income below 200% of federal poverty level). Key provisions require labs to maintain NJ FamilyCare reimbursement rates at the lower of the fee schedule or their standard public charge, while discounts to vulnerable patients must align with federal anti-rebate rules. The bill aims to prevent labs from ceasing discounted services due to prior enforcement risks under NJ FamilyCare regulations.